{"entity":{"type":"insider","cik":"0001313390","url":"/insider/0001313390","json_url":"/insider/0001313390.json","name":"Duvall Martin J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2005-12-20","last":"2019-05-29","span_basis":"filed_date"},"name_variants":[{"name":"Duvall Martin J","source":"filing","n_filings":10,"first_seen":"2005-12-20","last_seen":"2019-05-29"}],"transactions":[{"id":8204644,"accession":"0001209191-19-033190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-033190","line_url":"/filing/0001209191-19-033190#line-1","is_derivative":false,"issuer_cik":"0001313390","issuer_name":"Tocagen Inc","issuer_ticker":"TOCA","issuer_name_source":null,"issuer_url":"/issuer/0001313390","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.3357,"price_display":"4.34","price_state":"stated","total_value":21678.5,"total_display":"21,678.50","total_whole":"21,679","shares_owned_after":13605.0,"shares_owned_after_display":"13,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-29","scope":"insider"},{"id":2936252,"accession":"0000884731-16-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000884731-16-000025","line_url":"/filing/0000884731-16-000025#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Officer (EVP, CCO)","role_mark":"O","role_mark_label":"Officer (EVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":6.4667,"price_display":"6.47","price_state":"stated","total_value":25866.8,"total_display":"25,866.80","total_whole":"25,867","shares_owned_after":93039.0,"shares_owned_after_display":"93,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-19","filed_date":"2016-03-22","scope":"insider"},{"id":2278159,"accession":"0001127602-16-044965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-16-044965","line_url":"/filing/0001127602-16-044965#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Officer (EVP, CCO)","role_mark":"O","role_mark_label":"Officer (EVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9625.0,"shares_display":"9,625","price_per_share":6.1156,"price_display":"6.12","price_state":"stated","total_value":58862.65,"total_display":"58,862.65","total_whole":"58,863","shares_owned_after":89039.0,"shares_owned_after_display":"89,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-03","filed_date":"2016-03-03","scope":"insider"},{"id":3168203,"accession":"0001127602-16-039321","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-16-039321","line_url":"/filing/0001127602-16-039321#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Officer (EVP, CCO)","role_mark":"O","role_mark_label":"Officer (EVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14667.0,"shares_display":"14,667","price_per_share":4.812,"price_display":"4.81","price_state":"stated","total_value":70577.604,"total_display":"70,577.60","total_whole":"70,578","shares_owned_after":79414.0,"shares_owned_after_display":"79,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-01","filed_date":"2016-02-03","scope":"insider"},{"id":8287792,"accession":"0001127602-15-027741","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-027741","line_url":"/filing/0001127602-15-027741#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Officer (EVP, CCO)","role_mark":"O","role_mark_label":"Officer (EVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.4633,"price_display":"6.46","price_state":"stated","total_value":32316.5,"total_display":"32,316.50","total_whole":"32,317","shares_owned_after":64748.0,"shares_owned_after_display":"64,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-28","filed_date":"2015-09-28","scope":"insider"},{"id":8563380,"accession":"0001127602-15-022980","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-022980","line_url":"/filing/0001127602-15-022980#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Officer (EVP, CCO)","role_mark":"O","role_mark_label":"Officer (EVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":8.54,"price_display":"8.54","price_state":"stated","total_value":11956.0,"total_display":"11,956.00","total_whole":"11,956","shares_owned_after":59748.0,"shares_owned_after_display":"59,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-16","filed_date":"2015-07-16","scope":"insider"},{"id":8709735,"accession":"0001127602-15-012348","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-15-012348","line_url":"/filing/0001127602-15-012348#line-4","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Officer (EVP, CCO)","role_mark":"O","role_mark_label":"Officer (EVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":834.0,"shares_display":"834","price_per_share":8.5672,"price_display":"8.57","price_state":"stated","total_value":7145.0448,"total_display":"7,145.04","total_whole":"7,145","shares_owned_after":54950.0,"shares_owned_after_display":"54,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-23","filed_date":"2015-03-23","scope":"insider"},{"id":8709732,"accession":"0001127602-15-012348","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-15-012348","line_url":"/filing/0001127602-15-012348#line-3","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Officer (EVP, CCO)","role_mark":"O","role_mark_label":"Officer (EVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":8.8453,"price_display":"8.85","price_state":"stated","total_value":35381.2,"total_display":"35,381.20","total_whole":"35,381","shares_owned_after":54117.0,"shares_owned_after_display":"54,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-23","scope":"insider"},{"id":8052719,"accession":"0001127602-15-004332","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-004332","line_url":"/filing/0001127602-15-004332#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Officer (EVP, CCO)","role_mark":"O","role_mark_label":"Officer (EVP, CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14667.0,"shares_display":"14,667","price_per_share":6.3287,"price_display":"6.33","price_state":"stated","total_value":92823.0429,"total_display":"92,823.04","total_whole":"92,823","shares_owned_after":50117.0,"shares_owned_after_display":"50,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-04","scope":"insider"},{"id":4222778,"accession":"0001127602-13-011842","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-011842","line_url":"/filing/0001127602-13-011842#line-2","is_derivative":false,"issuer_cik":"0000884731","issuer_name":"ARIAD PHARMACEUTICALS INC","issuer_ticker":"ARIA","issuer_name_source":null,"issuer_url":"/issuer/0000884731","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Officer (SVP, Commercial Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":576.0,"shares_display":"576","price_per_share":19.53,"price_display":"19.53","price_state":"stated","total_value":11249.28,"total_display":"11,249.28","total_whole":"11,249","shares_owned_after":2854.0,"shares_owned_after_display":"2,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-22","filed_date":"2013-03-22","scope":"insider"},{"id":1305303,"accession":"0001181431-05-067827","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-05-067827","line_url":"/filing/0001181431-05-067827","is_derivative":false,"issuer_cik":"0000702131","issuer_name":"MGI PHARMA INC","issuer_ticker":"MOGN","issuer_name_source":null,"issuer_url":"/issuer/0000702131","owner_cik":"0001313390","owner_name":"Duvall Martin J","owner_display_name":"Duvall Martin J","owner_url":"/insider/0001313390","role":"Officer (Sr VP Commercial Operations)","role_mark":"O","role_mark_label":"Officer (Sr VP Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP Commercial Operations","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":16.5042,"price_display":"16.50","price_state":"stated","total_value":4951.26,"total_display":"4,951.26","total_whole":"4,951","shares_owned_after":6650.0,"shares_owned_after_display":"6,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-16","filed_date":"2005-12-20","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001419041","name":"Tocagen Inc","url":"/issuer/0001419041","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2019-05-29","last_seen":"2019-05-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000884731","name":"ARIAD PHARMACEUTICALS INC","url":"/issuer/0000884731","role":"Officer (EVP, CCO)","n_filings":8,"first_seen":"2013-03-22","last_seen":"2016-03-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000702131","name":"MGI PHARMA INC","url":"/issuer/0000702131","role":"Officer (Sr VP Commercial Operations)","n_filings":1,"first_seen":"2005-12-20","last_seen":"2005-12-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001313390","retrieved_at":"2026-08-25T19:08:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}